Neoplasm Metastases Clinical Trial
Official title:
Phase I Study To Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection Of Alpha-Gal Glycosphingolipids In Patients With Advanced Or Refractory Solid Tumors
This is a Phase I pilot study to evaluate the toxicity and feasibility of intratumoral injection (Glycosphingolipids) GSL alpha-GAL (beta-galactosidase) in patients with advanced, refractory solid tumors who have failed standard therapies or are not eligible for standard treatment.
Intratumoral injection of alpha gal glycolipid in experimental knockout mouse model systems incorporates into tumor cell membranes and presents these xeno-transplantation epitopes to antigen presenting cells with that particular tumor's tumor associated antigens (TAA). Thus this maneuver converts any individual tumor into an in situ tumor vaccine without the need to isolate, purify or supply TAA exogenously. The effects in these model systems demonstrate both the upregulation of cytotoxic T cells which react against the particular tumor's TAA, as well as resolution of injected primary tumor and eradication and prevention of metastatic disease at distant sites. This current study was undertaken to investigate the safety and feasibility of such an approach in humans. The major toxicity concerns are acute allergic or complement activation reactions or development of autoimmunity. The primary treatment is a single intratumoral injection of alpha gal glycolipid. The study design is a standard dose escalation design and the primary endpoint is Dose limiting toxicity at one month after injection (grade 3 or 4. Subjects are followed until death utilizing standard clinical imaging and evaluation to judge overall tumor response. ;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03911388 -
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
|
Phase 1 | |
Completed |
NCT02953756 -
Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)
|
||
Terminated |
NCT02565433 -
Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)
|
N/A | |
Completed |
NCT00184353 -
Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.
|
N/A | |
Recruiting |
NCT02789371 -
Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions
|
N/A | |
Completed |
NCT01122199 -
Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors
|
Phase 1 | |
Terminated |
NCT01336985 -
Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads
|
Phase 1 | |
Recruiting |
NCT05419518 -
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
|
Phase 2 | |
Completed |
NCT02808416 -
Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)
|
Phase 1 | |
Completed |
NCT00152906 -
Stereotactic Radiotherapy (SRT) Liver (COLD 1)
|
Phase 1/Phase 2 | |
Completed |
NCT01267084 -
A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT02327065 -
Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion
|
N/A | |
Completed |
NCT02382653 -
Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain
|
N/A | |
Completed |
NCT01273480 -
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
|
Phase 1 | |
Completed |
NCT01273493 -
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
|
Phase 1 | |
Completed |
NCT00556049 -
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
|
Phase 2 | |
Recruiting |
NCT02246634 -
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
|
N/A | |
Terminated |
NCT01970644 -
Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases
|
N/A |